What is Jasper Therapeutics, Inc. Common Stock's Market Cap?

Jasper Therapeutics, Inc. Common Stock's Market Cap is $17.0M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Enterprise Value?

Jasper Therapeutics, Inc. Common Stock's Enterprise Value is -$11.7M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's EV / EBITDA?

Jasper Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Net Income (TTM)?

Jasper Therapeutics, Inc. Common Stock's Net Income (TTM) is -$75.8M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's EBITDA?

Jasper Therapeutics, Inc. Common Stock's EBITDA is -$82.8M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.28, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Net Debt?

Jasper Therapeutics, Inc. Common Stock's Net Debt is -$28.7M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Jasper Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00QPZNPB4

0.51▲ 0.01 (2.91%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 0.50
Day's Range: 0.48 – 0.54
52-Week Range: 0.32 – 2.52
Volume: 323.5K
Avg Volume: 363.2K

Share Statistics

Shares Outstanding
Employees: 22
Exchange: XNAS
Listed: 2021-09-27

Share count as of August 10, 2026

Jasper Therapeutics, Inc. Common Stock (JSPR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Jasper Therapeutics, Inc. Common Stock (JSPR)

What is Jasper Therapeutics, Inc. Common Stock's Market Cap?: Jasper Therapeutics, Inc. Common Stock's Market Cap is $17.0M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Enterprise Value?: Jasper Therapeutics, Inc. Common Stock's Enterprise Value is -$11.7M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's EV / EBITDA?: Jasper Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Net Income (TTM)?: Jasper Therapeutics, Inc. Common Stock's Net Income (TTM) is -$75.8M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's EBITDA?: Jasper Therapeutics, Inc. Common Stock's EBITDA is -$82.8M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.28, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Net Debt?: Jasper Therapeutics, Inc. Common Stock's Net Debt is -$28.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · JSPRAs-filed SEC (XBRL) data